Print

ACADIA Pharmaceuticals, Inc. (ACAD) to Webcast Educational Program on Parkinson’s Disease Psychosis on May 22, 2012  
5/15/2012 10:11:52 AM

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will host a live webcast of its Educational Program on Parkinson’s Disease Psychosis to be held with analysts and investors in New York City on Tuesday, May 22, 2012, from 12:00 p.m. to 1:15 p.m. Eastern Time.
//-->